Long-term efficacy and reduced side-effects of buprenorphine in patients with moderate and severe chronic pain

• Egile Nagusiak: Alfonso Papa (Egilea), Anna Maria Salzano (Egilea), Maria Teresa Di Dato (Egilea), Vincenzo Desiderio (Egilea), Pietro Buonavolontà (Egilea), Pietro Mango (Egilea), Elisabetta Saracco (Egilea), Dario Tammaro (Egilea), Livio Luongo (Egilea), Sabatino Maione (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

BackgroundChronic pain significantly impacts quality of life and poses substantial public health challenges. Buprenorphine, a synthetic analog of thebaine, is recognized for its potential in managing moderate to severe chronic pain with fewer side effects and a lower incidence of tolerance compared...